SEARCH

SEARCH BY CITATION

References

  • 1
    Elliott PR, Lomas DA, Carrell RW & Abrahams J-P (1996) Inhibitory conformation of the reactive loop of α1-antitrypsin. Nat Struct Biol 3, 676681.
  • 2
    Ryu S-E, Choi H-J, Kwon K-S, Lee KN & Yu M-H (1996) The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved α1-antitrypsin at 2.7Å. Structure 4, 11811192.
  • 3
    Huntington JA, Read RJ & Carrell RW (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923926.
  • 4
    Dementiev A, Dobó J & Gettins PG (2006) Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha-1-proteinase inhibitor with porcine pancreatic elastase. J Biol Chem 281, 34523457.
  • 5
    Lomas DA & Mahadeva R (2002) Alpha-1-antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 110, 15851590.
  • 6
    Gooptu B & Lomas DA (2009) Conformational pathology of the serpins – themes, variations and therapeutic strategies. Ann Rev Biochem 78, 147176.
  • 7
    Sveger T (1976) Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 294, 13161321.
  • 8
    Eriksson S, Carlson J & Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency. N Engl J Med 314, 736739.
  • 9
    Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M & Lawrence DA (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurones. J Biol Chem 272, 3306233067.
  • 10
    Yepes M & Lawrence DA (2004) New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med 229, 10971104.
  • 11
    Davis RL, Holohan PD, Shrimpton AE, Tatum AH, Daucher J, Collins GH, Todd R, Bradshaw C, Kent P, Feiglin D et al. (1999) Familial encephalopathy with neuroserpin inclusion bodies (FENIB). Am J Pathol 155, 19011913.
  • 12
    Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Sonderegger P, Kinter J, Becker LM, Lacbawan F, Krasnewich D et al. (1999) Familial dementia caused by polymerisation of mutant neuroserpin. Nature 401, 376379.
  • 13
    Bradshaw CB, Davis RL, Shrimpton AE, Holohan PD, Rea CB, Fieglin D, Kent P & Collins GH (2001) Cognitive deficits associated with a recently reported familial neurodegenerative disease. Arch Neurol 58, 14291434.
  • 14
    Miranda E & Lomas DA (2006) Neuroserpin: a serpin to think about. Cell Mol Life Sci 17, 15271539.
  • 15
    Lomas DA, Finch JT, Seyama K, Nukiwa T & Carrell RW (1993) α1-antitrypsin Siiyama (Ser53[RIGHTWARDS ARROW]Phe); further evidence for intracellular loop-sheet polymerisation. J Biol Chem 268, 1533315335.
  • 16
    Miranda E, Pérez J, Ekeowa UI, Hadzic N, Kalsheker N, Gooptu B, Portmann B, Belorgey D, Hill M, Chambers S et al. (2010) A novel monoclonal antibody to characterise pathogenic polymers in liver disease associated with α1-antitrypsin deficiency. Hepatology 52, 10781088.
  • 17
    Belorgey D, Crowther DC, Mahadeva R & Lomas DA (2002) Mutant neuroserpin (Ser49Pro) that causes the familial dementia FENIB is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem 277, 1736717373.
  • 18
    Belorgey D, Sharp LK, Crowther DC, Onda M, Johansson J & Lomas DA (2004) Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Eur J Biochem 271, 33603367.
  • 19
    Miranda E, Römisch K & Lomas DA (2004) Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem 279, 2828328291.
  • 20
    Miranda E, McLeod I, Davies MJ, Pérez J, Römisch K, Crowther DC & Lomas DA (2008) The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB. Hum Mol Genet 17, 15271539.
  • 21
    Davis RL, Shrimpton AE, Carrell RW, Lomas DA, Gerhard L, Baumann B, Lawrence DA, Yepes M, Kim TS, Ghetti B et al. (2002) Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet 359, 22422247.
  • 22
    Coutelier M, Andries S, Ghariani S, Dan B, Duyckaerts C, van Rijckevorsel K, Raftopoulos C, Deconinck N, Sonderegger P, Scaravilli F et al. (2008) Neuroserpin mutation causes electrical status epilepticus of slow-wave sleep. Neurology 71, 6466.
  • 23
    Aulak KS, Eldering E, Hack CE, Lubbers YPT, Harrison RA, Mast A, Cicardi M & Davis AE III (1993) A hinge region mutation in C1-inhibitor (Ala436[RIGHTWARDS ARROW]Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem 268, 1808818094.
  • 24
    Eldering E, Verpy E, Roem D, Meo T & Tosi M (1995) COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J Biol Chem 270, 25792587.
  • 25
    Bruce D, Perry DJ, Borg J-Y, Carrell RW & Wardell MR (1994) Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn[RIGHTWARDS ARROW]Asp). J Clin Invest 94, 22652274.
  • 26
    Picard V, Dautzenberg M-D, Villoutreix BO, Orliaguet G, Alhenc-Gelas M & Aiach M (2003) Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerisation in vivo associated with severe childhood thrombosis. Blood 102, 919925.
  • 27
    Faber J-P, Poller W, Olek K, Baumann U, Carlson J, Lindmark B & Eriksson S (1993) The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol 18, 313321.
  • 28
    Poller W, Faber J-P, Weidinger S, Tief K, Scholz S, Fischer M, Olek K, Kirchgesser M & Heidtmann H-H (1993) A leucine-to-proline substitution causes a defective α1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 17, 740743.
  • 29
    Gooptu B, Hazes B, Chang W-SW, Dafforn TR, Carrell RW, Read R & Lomas DA (2000) Inactive conformation of the serpin α1-antichymotrypsin indicates two stage insertion of the reactive loop; implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 97, 6772.
  • 30
    Stein PE & Carrell RW (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 2, 96113.
  • 31
    Corral J, Aznar J, Gonzalez-Conejero R, Villa P, Minano A, Vaya A, Carrell RW, Huntington JA & Vicente V (2004) Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. Circulation 110, 13031307.
  • 32
    Green C, Brown G, Dafforn TR, Reichhart JM, Morley T, Lomas DA & Gubb D (2003) Mutations in the Drosophila serpin Necrotic mirror disease-associated mutations of human serpins. Development 130, 14731478.
  • 33
    Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P & Lomas DA (1999) A kinetic mechanism for the polymerisation of α1-antitrypsin. J Biol Chem 274, 95489555.
  • 34
    James EL & Bottomley SP (1998) The mechanism of α1-antitrypsin polymerization probed by fluorescence spectroscopy. Arch Biochem Biophys 356, 296300.
  • 35
    Lomas DA, Evans DL, Finch JT & Carrell RW (1992) The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 357, 605607.
  • 36
    Sivasothy P, Dafforn TR, Gettins PGW & Lomas DA (2000) Pathogenic α1-antitrypsin polymers are formed by reactive loop-b-sheet A linkage. J Biol Chem 275, 3366333668.
  • 37
    Purkayastha P, Klemke JW, Lavender S, Oyola R, Cooperman BS & Gai F (2005) α1-antitrypsin polymerisation: a fluorescence correlation spectroscopic study. Biochemistry 44, 26422649.
  • 38
    Cabrita LD, Dai W & Bottomley SP (2004) Different conformational changes within the F-helix occur during serpin folding, polymerization and proteinase inhibition. Biochemistry 43, 98349839.
  • 39
    Baek JH, Im H, Kang UB, Seong KM, Lee C, Kim J & Yu MH (2007) Probing the local conformational change of α1-antitrypsin. Protein Sci 16, 18421850.
  • 40
    Zhou A & Carrell RW (2008) Dimers initiate and propagate serine protease inhibitor polymerisation. J Mol Biol 375, 3642.
  • 41
    Chiou A, Hägglöf P, Orte A, Yuyin Chen A, Dunne P, Belorgey D, Karlsson-Li S, Lomas DA & Klenerman D (2009) Probing neuroserpin polymerization and interaction with amyloid-β peptides using single molecule fluorescence. Biophys J 97, 23062315.
  • 42
    Lomas DA, Elliott PR, Sidhar SK, Foreman RC, Finch JT, Cox DW, Whisstock JC & Carrell RW (1995) Alpha1-antitrypsin Mmalton (52Phe deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerisation. J Biol Chem 270, 1686416870.
  • 43
    Yu M-H, Lee KN & Kim J (1995) The Z type variation of human α1-antitrypsin causes a protein folding defect. Nat Struct Biol 2, 363367.
  • 44
    Kim J, Lee KN, Yi G-S & Yu M-H (1995) A thermostable mutation located at the hydrophobic core of α1-antitrypsin suppresses the folding defect of the Z-type variant. J Biol Chem 270, 85978601.
  • 45
    Kang HA, Lee KN & Yu M-H (1997) Folding and stability of the Z and Siiyama genetic variants of human α1-antitrypsin. J Biol Chem 272, 510516.
  • 46
    Devlin GL, Chow MKM, Howlett GJ & Bottomley SP (2002) Acid denaturation of α1-antitrypsin: characterization of a novel mechanism of serpin polymerization. J Mol Biol 324, 859870.
  • 47
    Ekeowa UI, Freekeb J, Miranda E, Gooptu B, Bush MF, Pérez J, Teckman J, Robinson CV & Lomas DA (2010) Defining the mechanism of polymerization in the serpinopathies. Proc Natl Acad Sci USA 107, 1714617151.
  • 48
    Carrell RW, Stein PE, Fermi G & Wardell MR (1994) Biological implications of a 3Å structure of dimeric antithrombin. Structure 2, 257270.
  • 49
    Zhang Q, Law RH, Bottomley SP, Whisstock JC & Buckle AM (2008) A structural basis for loop C-sheet polymerization in serpins. J Mol Biol 376, 13481359.
  • 50
    Bottomley SP, Hopkins PC & Whisstock JC (1998) Alpha 1-antitrypsin polymerisation can occur by both loop A and C sheet mechanisms. Biochem Biophys Res Commun 251, 15.
  • 51
    Chang W-SW, Whisstock J, Carrell RW & Wardell MR (1994) The mechanism of antithrombin polymerization: a pathological process. Blood 84(Suppl 1), 391a.
  • 52
    Sharp AM, Stein PE, Pannu NS, Carrell RW, Berkenpas MB, Ginsburg D, Lawrence DA & Read RJ (1999) The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure 7, 111118.
  • 53
    Zhou A, Faint R, Charlton P, Dafforn TR, Carrell RW & Lomas DA (2001) Polymerisation of plasminogen activator inhibitor-1. J Biol Chem 276, 91159122.
  • 54
    McGowan S, Buckle AM, Irving JA, Ong PC, Bashtannyk-Puhalovich TA, Kan WT, Henderson KN, Bulynko YA, Popova EY, Smith AI et al. (2006) X-ray crystal structure of MENT: evidence for functional loop-sheet polymers in chromatin condensation. EMBO J 25, 31443155.
  • 55
    Yamasaki M, Li W, Johnson DJ & Huntington JA (2008) Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 12551258.
  • 56
    Takehara S, Zhang J, Yang X, Takahashi N, Mikami B & Onda M (2010) Refolding and polymerization pathways of neuroserpin. J Mol Biol 403, 751762.
  • 57
    Belorgey D, Irving JA, Ekeowa UI, Freeke J, Roussel BD, Miranda E, Pérez J, Marciniak SJ, Crowther DC, Michel CH et al. (2011) Characterisation of serpin polymers in vitro and in vivo. Methods 53, 255266.
  • 58
    Huntington JA & Whisstock JC (2010) Molecular contortionism-on the physical limits of serpin ‘loop-sheet’ polymers. Biol Chem 391, 973982.
  • 59
    Graham KS, Le A & Sifers RN (1990) Accumulation of the insoluble PiZ variant of human α1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP. J Biol Chem 265, 2046320468.
  • 60
    Hidvegi T, Schmidt BZ, Hale P & Perlmutter DH (2005) Accumulation of mutant alpha-1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem 280, 3900239015.
  • 61
    Teckman JH & Perlmutter DH (2000) Retention of mutant α1-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 279, G961G974.
  • 62
    Kamimoto T, Shoji S, Hidvegi T, Mizushima N, Umebayashi K, Perlmutter DH & Yoshimori T (2006) Intracellular inclusions containing mutant alpha-1-antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem 281, 44674476.
  • 63
    Kröger H, Miranda E, MacLeod I, Pérez J, Crowther DC, Marciniak SJ & Lomas DA (2009) Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J Biol Chem 284, 2279322802.
  • 64
    Davies MJ, Miranda E, Roussel BD, Kaufman RJ, Marciniak SJ & Lomas DA (2009) Neuroserpin polymers activate NF-κB by a calcium signalling pathway that is independent of the unfolded protein response. J Biol Chem 284, 1820218209.
  • 65
    Pahl HL & Baeuerle PA (1995) A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J 14, 25802588.
  • 66
    Burrows JAJ, Willis LK & Perlmutter DH (2000) Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z: a potential pharmacologcial strategy for prevention of liver injury and emphysema. Proc Natl Acad Sci USA 97, 17961801.
  • 67
    Teckman JH (2004) Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J Pediatr Gastroenterol Nutr 39, 3437.
  • 68
    Sharp LK, Mallya M, Kinghorn KJ, Wang Z, Crowther DC, Huntington JA, Belorgey D & Lomas DA (2006) Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J 273, 25402552.
  • 69
    Mallya M, Phillips RL, Saldanha SA, Gooptu B, Leigh Brown SC, Termine DJ, Shirvani AM, Wu Y, Sifers RN, Abagyan R et al. (2007) Small molecules block the polymerisation of Z α1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem 50, 53575363.
  • 70
    Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maurice N, Mukherjee A, Goldbach C, Watkins S et al. (2010) An autophagy-enhancing drug promotes degradation of mutant alpha-1-antitrypsin Z and reduces hepatic fibrosis. Science 329, 229232.
  • 71
    Kaushal S, Annamali M, Blomenkamp K, Rudnick D, Halloran D, Brunt EM & Teckman JH (2010) Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model. Exp Biol Med (Maywood) 235, 700709.
  • 72
    Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J et al. (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 120, 31273136.
  • 73
    Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ & Rubinsztein DC (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170, 11011111.
  • 74
    Marciniak SJ & Lomas DA (2010) Alpha-1-antitrypsin deficiency and autophagy. N Engl J Med 363, 18631864.